BioRestorative Therapies, Inc. SEC filings BRTX
BioRestorative Therapies, Inc. has 754 filings in SEC EDGAR's recent list, going back to Nov 16, 2010. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 13, 2026 | May 26, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2026 | May 26, 2026 |
| DEF 14A | Proxy statement | Aug 8, 2025 | Aug 8, 2025 |
| DEF 14A | Proxy statement | Aug 8, 2024 | Sep 19, 2024 |
| DEF 14A | Proxy statement | Aug 4, 2023 | Sep 13, 2023 |
| DEF 14A | Proxy statement | Sep 23, 2022 | Nov 3, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 5, 2022 | Aug 5, 2022 |
| DEFA14A | Additional proxy material | Aug 12, 2021 | — |
| DEFA14A | Additional proxy material | Jul 19, 2021 | — |
| DEF 14A | Proxy statement | Jul 7, 2021 | Aug 17, 2021 |
| PRE 14A | Preliminary proxy statement | Jun 25, 2021 | Aug 17, 2021 |
| DEF 14A | Proxy statement | Dec 23, 2019 | Dec 23, 2019 |
| PRE 14A | Preliminary proxy statement | Dec 13, 2019 | Jan 8, 2020 |
| DEFA14A | Additional proxy material | Nov 1, 2019 | — |
| DEF 14A | Proxy statement | Oct 28, 2019 | Nov 13, 2019 |
| PRE 14A | Preliminary proxy statement | Oct 18, 2019 | Oct 18, 2019 |
| DEF 14A | Proxy statement | Aug 15, 2019 | Aug 30, 2019 |
| PRE 14A | Preliminary proxy statement | Aug 2, 2019 | Aug 28, 2019 |
| DEF 14A | Proxy statement | Apr 18, 2019 | Apr 18, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2019 | May 30, 2019 |
| DEF 14A | Proxy statement | Jul 10, 2018 | Aug 21, 2018 |
| PRE 14A | Preliminary proxy statement | Jun 22, 2018 | Aug 21, 2018 |
| DEF 14A | Proxy statement | Jul 28, 2017 | Jul 28, 2017 |
| DEF 14A | Proxy statement | Sep 8, 2016 | Sep 7, 2016 |
| DEF 14A | Proxy statement | Nov 12, 2015 | Dec 22, 2015 |
| DEF 14A | Proxy statement | Apr 21, 2015 | May 28, 2015 |
| PRE 14A | Preliminary proxy statement | Apr 8, 2015 | May 28, 2015 |
| DEF 14A | Proxy statement | Nov 7, 2014 | Dec 19, 2014 |
| PRE 14A | Preliminary proxy statement | Oct 27, 2014 | Dec 19, 2014 |
| DEF 14A | Proxy statement | Aug 22, 2013 | Aug 16, 2013 |
| DEF 14A | Proxy statement | Oct 23, 2012 | Oct 22, 2012 |
| PRE 14A | Preliminary proxy statement | Oct 5, 2012 | Dec 7, 2012 |
| DEF 14A | Proxy statement | Dec 23, 2011 | Feb 10, 2012 |
| PRE 14A | Preliminary proxy statement | Dec 12, 2011 | Dec 9, 2011 |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- BRTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Melville, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1505497
- Former names
- Stem Cell Assurance, Inc. (until Aug 16, 2011)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
All 15 Services-Misc Health & Allied Services, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.